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TCTAP A-051
Changes in Cardiac Form and Function Before and After Transcatheter
Closure of Secundum Atrial Septal Defects
Ramesh Gadepalli,1 Nagamurali Kosuri1
1Nizam’s Institute of Medical Sciences, India
BACKGROUND Inpatients with congenital heart disease, right ven-
tricular (RV) function is an important prognostic factor but the
assessment of RV function remains difﬁcult, mainly because of the
complex geometry and the thin myocardial wall. Myocardial perfor-
mance index (MPI) is a measure of combined Ventricular systolic and
diastolic function .In congenital heart disease parameters of contrac-
tile function are inﬂuenced by different loading conditions. In
contrast to myocardial velocities, deformation parameters SR (strain
rate) and ε are less inﬂuenced by global cardiac motion and by teth-
ering of myocardial segments. Longitudinal systolic ε and SR have
been validated as reliable techniques for the evaluation of RV function
under various loading conditions.
OBJECTIVES To study the effect of transcatheter closure of atrial
septal defect (ASD) on right ventricular (RV) and left ventricular (LV)
function, as well as left atrial (LA) volumes and the inﬂuence of pre-
load alterations on systolic right ventricular (RV) velocities and
deformation indices in patients with atrial septal defect (ASD).
METHODS During a 12 month period from July 2013 through June
2014, 50 patients scheduled for percutaneous closure of an ASD were
prospectively enrolled in the study. Pre and post-ASD device closure
at 1 week echocardiograms of 50 consecutive patients were done.
Measurements of RV and LVMPI and LA volumes were taken. Longi-
tudinal peak systolic velocities, peak systolic strain rate (SR), and end
systolic strain (V) were calculated in the mid-segment of the RV free
wall and the septum.
RESULTS 50 patients with an average age of 32.5  16.3 years un-
derwent transcatheter closure of ASD. There was statistically sig-
niﬁcant improvement in RV MPI (0.33 to 0.29, p 0.003), LV MPI (0.35
to 0.30, p 0.03), and LA volume index (27.1 to 22.3 ml/m2, p 0.001)
after closure of ASD. After ASD closure Indexed measurements of RV
long-axis dimension was signiﬁcantly reduced (69.818.6 to
67.33,p 0.0005) and of RV inlet (45.915.3 to 42.513.5, NS),
tricuspid valve annulus (29.98.3 to 27.98.1, NS) and RV short axis
(30.16.9 to 28.28.3,NS) are insigniﬁcantly decreased. Peak systolic
velocities recorded from the RV free wall returned to normal phys-
iologic Values which are initially higher (9.92.3 to 7.43.8,
p <0.001) And at the interventricular septum, they tended to be
higher in patients with ASD compared with control subjects showed
a signiﬁcant decline to subnormal values (4.11.2 to 3.21.3, p 0.002)
after closure of the defect. Peak systolic SR (RV mid.-3.61. to
-3.41.7 and septal-2.10.6 to -1.70.6) and end systolic ε (RV mid.
-48.314.2 to -45.1311.6 and septal -31.214.1 to 27.38.3) which are
slightly higher compared with normal physiological values, showed a
diminishing tendency after closure of ASD, however, the difference
was not signiﬁcant.
CONCLUSION In congenital ASD RV adaptation to a longstanding
volume overload causes slightly increased systolic longitudinal
deformation suggests an adequate structural and physiologic adap-
tation of the RV to chronic volume overload. After relief of volume
overload, RV longitudinal systolic deformation indices tended to
decrease, but not signiﬁcantly, in contrast, peak systolic velocities
decreased signiﬁcantly suggesting that myocardial velocities are
clearly load dependent whereas deformation indices are relatively
pre-load stable measures of ventricular contractility.TCTAP A-052
Experiences of Combined Treatments of Selective Pulmonary Vasodilators
After the Transcatheter Closure in Atrial Septal Defect with Pulmonary
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BACKGROUND The clinical course of patient with transcatheter
closure of atrial septal defect (ASD) with pulmonary arterial hyper-
tension (PAH) has not been completely understood. Variable pattern
of the disease progression and the severity of disease in similarunderlying defects may be the important factors to predict the clinical
outcome.
METHODS From May 2006 to June 2012, 457 patients underwent
transcatheter closure of ASD. Among them, 68 patients had PAH at the
time of procedure. PAH was classiﬁed as mild (40-49mmHg), moder-
ate (50-59mmHg), severe (above 60mmHg) according to pulmonary
artery systolic pressure (PASP). We reviewed the course of the PAH
and complications in these subjects.
RESULTS In mild PAH group (n¼37), thirty two patients had normal-
ization after the transcatheter closure of ASD, and the remained pa-
tients had normalization within 1 month. In moderate PAH group
(n¼17), thirteen patients showed normal PA pressure after closure of
ASD, and 4 patients normalized within during follow-up. In severe
PAH group (n¼14), there was no patient who showed immediate
normalization after transcatheter closure. During follow-up period,
normal PA pressure was shown in 12 patients who had remaining PAH
after the procedure. No signiﬁcant complications related to ASD oc-
clusion and PAH were demonstrated.
CONCLUSION Patients with Atrial septal defect with pulmonary hy-
pertension have more complex clinical and pathophysiologic charac-
teristics. Therefore, treatment strategy in congenital heart disease
patients with pulmonary hypertension should be tailored to individ-
ual details of disease as well as general measures targeting the pul-
monary arterial hypertension.
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Clinical Usefulness of Computed Tomography in the Details of Atrial Septal
Defect Before Transcatheter Closure
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BACKGROUND Transcatheter atrial septal defect occlusion (ASO) in
adult patients has been increasing. Pre-procedural survey for the
feasibility based on the defect diameter and each rim is determined
mainly by transesophageal echocardiography (TEE). However, the
role of computed tomography (CT) was not fully understood in pre-
ASO procedure.
METHODS We assessed consecutive 11 patients (2 male and 9 female)
with ASD by CT and TEE. The size of atrial septal defect was compared
between CT and TEE. In addition, we evaluated rim defect, abnor-
malities of pulmonary venous return, and coronary artery stenosis.
RESULTS Mean age was 64.46.2. The size of largest defect was
similarly measure between CT and TEE (CT: 17.94.4 mm vs. TEE:
17.23.3mm;r¼0.84, p<0.01). There were positive correlations be-
tween CT and TEE for measurement of aortic rim (r¼0.85, p<0.01) and
superior rim (r¼0.79, p<0.01). CT examination detected 2 patients
who were not feasible for ASO due to a broad lack of aortic to superior
rim and partial anomalous pulmonary venous connection type. Cor-
onary artery disease was evaluable in all cases.
CONCLUSION CT may be useful for pre-ASO-procedural assessment
consisted of the size of atrial septal defect, rim defect and abnor-
malities of pulmonary venous return in adult patients.
TCTAP A-054
VSD Transcatheter Closure Is an Accepted Mode of Treatment in Selected
Cases of Congenital Heart Disease. Lately, This Technology Has Been
Applied to Closure of Ventricular Septal Defect (VSD)
Manoj Bhavrilal Chopda1
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BACKGROUND Transcatheter closure of ventricular septal defect us-
ing PDA devices is gaining acceptance in selected cases as compare to
surgical closure which is associated with morbidity and mortality. Po-
tential advantages of the transcatheter closure over conventional sur-
gery include a smaller incision, shorter stay and fewer complications.
METHODS 78 Cases under went echo and cardiac cath. Out of 78 pa-
tients 10 patients send to surgery because of improper size or location
of the VSD. 68 cases were having defect size ranging from 3mm to
10mm. The location of VSD was perimembranous in 60 cases,
muscular in 08 cases and apical in 01 case. The procedure was per-
formed in 68 cases with PDA device.
PROCEDURE LV Angiography showed VSD. Lima Catheter was passed
in LV with rotation and pull back technique, then crossed VSD and
was placed in RV. Double length Terumo 0.03500 x260 cm wire was
taken and passed through RV, RA, IVC, SVC or PA. Snared through
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Terumo wire. PDA Sheath was passed through RA, RV and then into
Aorta with Kissing technique sheath was positioned in LV. PDA device
was loaded in sheath. Device was positioned on LV side ﬁrst and then
on RV side. Position was checked on 2D-Echo which was found to be
accurate. Wire and catheter was removed. Post procedure treatment
with steroids was advised as per standard treatment. Antiplatelet
aspirin was recommended for one month.
RESULTS Procedure was done successfully in 66 without any com-
plications. In 15 cases Transient BBB was developed on during pro-
cedure. In 1 case complication of CHB occurred during procedure in
which temporary pace maker (TPM) was implanted for 3 days. In
another case, complication of CHB occurred in ICU after 3 hours in
which TPM was done for 2 days. In 2 cases device was embolized, 1
device successfully retrieved with help of the basket snare and
continued procedure with bigger size device, another 1 case went to
surgery. 1 case of death was observed on 5thday, which was due to
stroke. At 1 year follow up no shunt was noted in ECHO and ECG
remained same with no additional conditional defect.
CONCLUSION Transcatheter closure is safe and efﬁcacious in selected
cases of perimembranous and muscular VSD using PDA device. Tras-
catheter closure of ventricular septal defect using PDA devices is
gaining acceptance in selected cases as compare to surgical closure
which is associated with morbidity and mortality. Potential advan-
tages of the transcatheter closure over conventional surgery include a
smaller incision, shorter stay and fewer complications.
TCTAP A-055
Transcatheter Closure of Large PDA with Custom Made Devices: Useful
Alternative to Surgery
Manojkumar Rohit,1 Ankur Gupta,1 Parag Barwad1
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BACKGROUND Transcatheter closure of patent ductus arteriosus
(PDA) is a simple, safe and effective procedure, being done
throughout the world. Since the ﬁrst use of Ivalon plugin 1967 (1), no
other shunt lesion has seen so much advancement in the development
of device technology as PDA, the latest being the second generation
Amplatzer vascular plugs (St Jude Medical, Plymouth, IN, USA).
However, the maximum sizes available amongst the commonly used
devices are 16/14 mm for Amplatzer duct occluder I (AGA Medical
corporation, Golden Valley, MN, USA), 22mm for Amplatzer vascular
plug II and 24/22 mm for Cera PDA occluder (Lifetech Scientiﬁc,
Shenzhen, China).
In developing countries, many patients with large PDA present late
in life. In the absence of large size devices, the only option left for
these patients is surgical ligation. Here we report four patients with
large PDA, and their transcatheter closure with custom made large
PDA occluder or muscular ventricular septal defect (VSD) occluder.
We are presenting six cases of large PDA measuring 14-16 mm in
young adolescent & adult where in in four cases were closed with
30/28 mm PDA from life tech china & in two cases 24mm muscular
VSD device was used. PDA device used was two times the size of PDA.
In two children on 12 years PDA 30/28 was too large & was changed to
24 mm muscular VSD device successfully.
CONCLUSIONS Patients with large PDA diagnosed late in life are
commonly seen in developing countries. Dedicated custom-made
transcatheter devices can be used successfully for transcatheter
closure of these PDA without signiﬁcant complications instead of
using expensive muscular VSD occluders or surgery.
METHODS Case 1
A 16 years old patient was referred with an incidentally detected
murmur. On examination, she had a continuous murmur in the left
ﬁrst and second intercostal spaces. Echocardiography showed a large
PDA with enlarged left atrium (LA) and left ventricle (LV) and pre-
served left ventricular systolic function. After an informed consent,
she was taken up for cardiac catheterization and device closure. Both
femoral artery and vein were accessed after giving local anaesthesia.
Hemodynamic study revealed pulmonary artery systolic pressure
(PSAP) of 48 mmHg, systemic systolic pressure of 130 mmHg, Qp/Qs of
2.83 and PVR/SVR of 0.09. Descending aortogram was done using a 6F
pigtail catheter (Cordis corporation, Florida, USA) and ductus size was
measured to be 15 mm in lateral view.After crossing the PDA from pulmonary artery side using a Multi-
purpose catheter (Cordis corporation, Florida, USA), a 0.035 inch, and
260cm Amplatzer extra stiff guide wire (AGA Medical Corporation,
Golden Valley, MN, USA) was introduced. A 14F cook delivery sheath
(Cook, Bloomington, IN) was inserted over the guidewire and a 24 mm
atrial septal defect occluder (AGA Medical corporation, Golden Valley,
MN, USA) was positioned across the PDA. A check angiogram showed
substantial ﬂow across the device.
